| URL | https://www.tampabay.com/business/biotech-research |
| Source | Tampa Bay Times |
| Date Published | 02/22/2019 |
| Author Name | Richard Danielson |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Vycellix |
| Parent company | Vycellix |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Country(ies) from which reshored: | Sweden |
| City reshored to: | Tampa |
| State(s) reshored to: | FL |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | gene therapy |
| What domestic positive factors made reshoring more attractive? | Proximity to customers/market |